0001062993-23-019700.txt : 20231025 0001062993-23-019700.hdr.sgml : 20231025 20231025163044 ACCESSION NUMBER: 0001062993-23-019700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231023 FILED AS OF DATE: 20231025 DATE AS OF CHANGE: 20231025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frieberg Jacob B. CENTRAL INDEX KEY: 0001748346 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38624 FILM NUMBER: 231346398 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVENUE CITY: ROCHESTER STATE: NY ZIP: 14620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINEX, INC. CENTRAL INDEX KEY: 0001205922 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161603202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 BUSINESS PHONE: 585-271-2700 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 FORMER COMPANY: FORMER CONFORMED NAME: VACCINEX INC DATE OF NAME CHANGE: 20021114 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-10-23 0001205922 VACCINEX, INC. VCNX 0001748346 Frieberg Jacob B. C/O VACCINEX, INC. 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620 1 0 0 0 0 Common Stock 4235 D Common Stock 6301 I By Benbow Estates, Ltd. Common Stock 12870 I By Gee Eff Services Limited Stock Option (Right to Buy) 204.0 2027-09-15 Common Stock 426 426 D Stock Option (Right to Buy) 78.9 2029-03-30 Common Stock 166 166 D Stock Option (Right to Buy) 116.7 Common Stock 514 514 D Stock Option (Right to Buy) 82.8 2029-06-29 Common Stock 159 159 D Stock Option (Right to Buy) 107.55 2029-09-27 Common Stock 123 123 D Stock Option (Right to Buy) 72.75 2029-12-28 Common Stock 182 182 D Stock Option (Right to Buy) 60.0 2030-03-29 Common Stock 222 222 D Stock Option (Right to Buy) 59.25 Common Stock 1045 1045 D Stock Option (Right to Buy) 54.15 2030-06-28 Common Stock 250 250 D Stock Option (Right to Buy) 26.7 2030-09-28 Common Stock 508 508 D Stock Option (Right to Buy) 31.05 2030-12-29 Common Stock 436 436 D Stock Option (Right to Buy) 44.7 2031-03-31 Common Stock 302 302 D Stock Option (Right to Buy) 32.25 Common Stock 1905 1905 D Stock Option (Right to Buy) 42.0 2031-06-28 Common Stock 320 320 D Stock Option (Right to Buy) 32.4 2031-09-28 Common Stock 415 415 D Stock Option (Right to Buy) 15.6 2031-12-29 Common Stock 857 857 D Stock Option (Right to Buy) 19.8 2032-03-28 Common Stock 668 668 D Stock Option (Right to Buy) 16.8 Common Stock 3550 3550 D Stock Option (Right to Buy) 16.2 2032-06-27 Common Stock 804 804 D Stock Option (Right to Buy) 7.43 2032-09-27 Common Stock 1750 1750 D Stock Option (Right to Buy) 9.68 2032-12-28 Common Stock 1323 1323 D Stock Option (Right to Buy) 5.99 2033-03-28 Common Stock 2140 2140 D Stock Option (Right to Buy) 6.15 2024-05-11 Common Stock 9589 9589 D Stock Option (Right to Buy) 5.34 2033-06-27 Common Stock 2414 2414 D Stock Option (Right to Buy) 1.13 2023-10-23 4 D 0 11291 0.77 D 2023-09-29 2033-09-26 Common Stock 11291 0 D Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Mr. Frieberg is the sole owner and President of Gee Eff Services Limited. Exercisable in full as of the date of this report. This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first. This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023. On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of stock options and underlying shares of common stock in this Form 4 reflect the Reverse Stock Split. /s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg 2023-10-25